Tag: IPF
ADOCIA announces the receipt of 500,000 euros for the exercise by IPF Partners of part of its share subscription warrants – 08/31/2023 at 6:00 p.m.
6:00 p.m. CEST – Adocia (Euronext Paris: FR0011184241 – ADOC), the clinical-stage biopharmaceutical company specializing in the development of innovative formulations of proteins and peptides for the treatment of diabetes…
Adocia receives 500,000 euros after the exercise of part of the BSAs of IPF partners – 08/31/2023 at 6:23 p.m.
(AOF) – Adocia announced the exercise by IPF Partners of part of its share subscription warrants (BSA), giving rise to the issue of 204,919 shares at a price of 2.44…
Adocia receives 500,000 euros after the exercise of part of the BSAs of IPF partners
(AOF) – Adocia announced the exercise by IPF Partners of part of its share subscription warrants (BSA), giving rise to the issue of 204,919 shares at a price of 2.44…
Boehringer Ingelheim, partner of VIK, the application to support patients with Idiopathic Pulmonary Fibrosis (IPF)
Paris, January 17, 2022 – Developed by the start-up Wefight with the institutional support of Boehringer Ingelheim, the Vik FPI application is the first solution designed to support and inform…